---All---
  • ---All---
  • Accession
  • Catalog #

AGTRAP Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP18437b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP18437b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AGTRAP Antibody (C-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ6RW13
Other AccessionNP_001035284.1
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW17419 Da

AGTRAP Antibody (C-term) - Additional info

Gene ID 57085
Other Names
AGTRAP; ATRAP; Type-1 angiotensin II receptor-associated protein; AT1 receptor-associated protein
Target/Specificity
This AGTRAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 132-159 amino acids from the C-terminal region of human AGTRAP.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AGTRAP Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

AGTRAP Antibody (C-term) - Protein Information

Name AGTRAP
Synonyms ATRAP
Function
Appears to be a negative regulator of type-1 angiotensin II receptor-mediated signaling by regulating receptor internalisation as well as mechanism of receptor desensitization such as phosphorylation. Induces also a decrease in cell proliferation and angiotensin II-stimulated transcriptional activity
Cellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein. Cytoplasmic vesicle membrane; Multi-pass membrane protein. Note=Present in perinuclear vesicular membranes, Endoplasmic reticulum, Golgi and endocytic vesicles
Tissue Location
Ubiquitous but more abundant in kidney, heart, pancreas and thyroid

AGTRAP Antibody (C-term) - Related products

AP18437b: AGTRAP Antibody (C-term)

RI10175: AGTRAP predesign siRNA

AT1069a: AGTRAP Antibody (monoclonal) (M02)

AGTRAP Antibody (C-term) - Application data

  • AGTRAP Antibody (C-term) (Cat. #AP18437b) western blot analysis in SK-BR-3 cell line lysates (35ug/lane).This demonstrates the AGTRAP Antibody detected the AGTRAP protein (arrow).

AGTRAP Antibody (C-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a transmembrane protein localized to the plasma membrane and perinuclear vesicular structures. The gene product interacts with the angiotensin II type I receptor and negatively regulates angiotensin II signaling. Alternative splicing of this gene generates multiple transcript variants encoding different isoforms.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Godin, C.M., et al. Mol. Pharmacol. 77(3):388-395(2010) Rabbitts, J.A., et al. J. Physiol. (Lond.) 587 (PT 22), 5441-5449 (2009) : Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009) Newton-Cheh, C., et al. Nat. Genet. 41(6):666-676(2009)